News

Quantum BioPharma (NASDAQ: QNTM) has appointed Kevin Malone as an advisor to its Board of Directors. A seasoned financial advisor with over 40 years ...
Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) (FSE: 0K91) (Upstream: QNTM) ("Quantum BioPharma" or the "Company"), a biopharmaceutical company dedicated to building a portfolio of innovative ...
Mr. Malone is a 2nd generation financial advisor with over 40 years of family experience in wealth management. This combined with his deep entrepreneurial background he launched Malone Wealth in 2021.
UPS is expanding its precision logistics capabilities in the pharmaceutical and life sciences sectors with an agreement to purchase Andlauer Healthcare Group in Canada.
About Quantum BioPharma ... and medical uses. Quantum BioPharma maintains a portfolio of strategic investments through its wholly owned subsidiary, FSD Strategic Investments Inc., which represents ...
Revolutionary Patented Technology Poised to Address Unmet Medical ... ABVC BioPharma, Inc. (NASDAQ: ABVC), a clinical-stage biopharmaceutical company advancing therapeutic solutions in ...
TORONTO, March 27, 2025 (GLOBE NEWSWIRE) -- Quantum BioPharma Ltd ... pharmaceutical and medical uses. Quantum BioPharma maintains a portfolio of strategic investments through its wholly owned ...
Rocket Pharmaceuticals appointed Sarbani Chaudhuri as chief commercial and medical affairs officer. Medtech Butterfly Medical named Cleveland Clinic urologist Dr. James Ulchaker as chief medical ...
"We are excited to see that the FDA is elevating its continued commitment to reduce animal testing through innovative science, as outlined in the new Roadmap to Reducing Animal Testing in Preclinical ...
Fangzhou Inc. ("Fangzhou" or the "Company") (06086.HK), a leading Internet healthcare solution provider, participated in the "AI Empowers Biopharma" exchange panel hosted by the Guangzhou Development ...
The market for real-world evidence (RWE) solutions market is expected to grow CAGR of ~10% during the forecast period. The major reasons for this growth include growing regulatory support for RWE ...